Author
Listed:
- Ilya Osterman
(Weizmann Institute of Science)
- Hadar Samra
(Weizmann Institute of Science)
- Francois Rousset
(Weizmann Institute of Science)
- Elena Loseva
(Weizmann Institute of Science)
- Maxim Itkin
(Weizmann Institute of Science)
- Sergey Malitsky
(Weizmann Institute of Science)
- Erez Yirmiya
(Weizmann Institute of Science)
- Adi Millman
(Weizmann Institute of Science)
- Rotem Sorek
(Weizmann Institute of Science)
Abstract
Bacteria defend against phage infection through a variety of antiphage defence systems1. Many defence systems were recently shown to deplete cellular nicotinamide adenine dinucleotide (NAD+) in response to infection, by cleaving NAD+ into ADP-ribose (ADPR) and nicotinamide2–7. It was demonstrated that NAD+ depletion during infection deprives the phage of this essential molecule and impedes phage replication. Here we show that a substantial fraction of phages possess enzymatic pathways allowing reconstitution of NAD+ from its degradation products in infected cells. We describe NAD+ reconstitution pathway 1 (NARP1), a two-step pathway in which one enzyme phosphorylates ADPR to generate ADPR pyrophosphate (ADPR-PP), and the second enzyme conjugates ADPR-PP and nicotinamide to generate NAD+. Phages encoding NARP1 can overcome a diverse set of defence systems, including Thoeris, DSR1, DSR2, SIR2–HerA and SEFIR, all of which deplete NAD+ as part of their defensive mechanism. Phylogenetic analyses show that NARP1 is primarily encoded on phage genomes, suggesting a phage-specific function in countering bacterial defences. A second pathway, NARP2, allows phages to overcome bacterial defences by building NAD+ using metabolites different from ADPR-PP. Our findings reveal a unique immune evasion strategy in which viruses rebuild molecules depleted by defence systems, thus overcoming host immunity.
Suggested Citation
Ilya Osterman & Hadar Samra & Francois Rousset & Elena Loseva & Maxim Itkin & Sergey Malitsky & Erez Yirmiya & Adi Millman & Rotem Sorek, 2024.
"Phages reconstitute NAD+ to counter bacterial immunity,"
Nature, Nature, vol. 634(8036), pages 1160-1167, October.
Handle:
RePEc:nat:nature:v:634:y:2024:i:8036:d:10.1038_s41586-024-07986-w
DOI: 10.1038/s41586-024-07986-w
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:634:y:2024:i:8036:d:10.1038_s41586-024-07986-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.